ArticleFrontiers in digital health2026
Generative AI as a de facto mental health provider: a policy brief and urgent call for regulation.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generative AI platforms such as ChatGPT, Claude, and Gemini have become de facto mental health resources for millions of users worldwide, driven by accessibility, low cost, anonymity, and growing gaps in professional care. This rapid, unregulated adoption raises urgent concerns: misinformation from AI hallucinations, erosion of data privacy, algorithmic bias, emotional dependency, and the undermining of user autonomy. At the same time, these tools offer real promise as low-barrier entry points to psychoeducation, self-reflection, and support for underserved populations. This policy brief synthesizes the current evidence on public use of general-purpose GenAI for mental health support, outlines both opportunities and risks, and provides actionable recommendations for users, clinicians, developers, and regulators.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.